Treatment of overlapping asthma-chronic obstructive pulmonary disease: Can guidelines contribute in an evidence-free zone?

Journal of Allergy and Clinical Immunology

Volumn 136, Issue 3, 2015, Pages 546-552

  Reddel, Helen K ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Asthma; asthma chronic obstructive pulmonary disease overlap syndrome; chronic obstructive pulmonary disease; guidelines

Indexed keywords

BRONCHODILATING AGENT; LONG ACTING DRUG; MUSCARINIC RECEPTOR BLOCKING AGENT; ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ASTHMA; AUSTRALIA; CANADA; CHRONIC OBSTRUCTIVE LUNG DISEASE; FINLAND; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PHENOTYPE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; REVIEW; RISK FACTOR; SPAIN; UNITED KINGDOM; UNITED STATES; DIFFERENTIAL DIAGNOSIS; DISEASE MANAGEMENT; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; NOMENCLATURE; PATHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ANTI-ASTHMATIC AGENTS; ASTHMA; DIAGNOSIS, DIFFERENTIAL; DISEASE MANAGEMENT; HUMANS; MUSCARINIC ANTAGONISTS; PHENOTYPE; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TERMINOLOGY AS TOPIC;

EID: 84941126995     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.06.043     Document Type: Article

References (57)

1. Global strategy for asthma management and prevention. Updated 2015. Available at: http://www.ginasthma.org. Accessed May 15, 2015.
2. Global Strategy for the diagnosis, management and prevention of COPD. Updated 2015. Available at: www.goldcopd.org.
3. J.E. Tomlinson, A.D. McMahon, R. Chaudhuri, J.M. Thompson, S.F. Wood, and N.C. Thomson Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma Thorax 60 2005 282 287
4. F.D. Martinez The origins of asthma and chronic obstructive pulmonary disease in early life Proc Am Thorac Soc 6 2009 272 277
5. M. Weatherall, J. Travers, P.M. Shirtcliffe, S.E. Marsh, M.V. Williams, M.R. Nowitz, and et al. Distinct clinical phenotypes of airways disease defined by cluster analysis Eur Respir J 34 2009 812 818
6. S.E. Marsh, J. Travers, M. Weatherall, M.V. Williams, S. Aldington, P.M. Shirtcliffe, and et al. Proportional classifications of COPD phenotypes Thorax 63 2008 761 767
7. M. Hardin, E.K. Silverman, R.G. Barr, N.N. Hansel, J.D. Schroeder, B.J. Make, and et al. The clinical features of the overlap between COPD and asthma Respir Res 12 2011 127
8. E. Pizzichini, M.M. Pizzichini, P. Gibson, K. Parameswaran, G.J. Gleich, L. Berman, and et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis Am J Respir Crit Care Med 158 1998 1511 1517
9. I.D. Pavord, C.E. Brightling, G. Woltmann, and A.J. Wardlaw Non-eosinophilic corticosteroid unresponsive asthma Lancet 353 1999 2213 2214
10. S.E. Wenzel, L.B. Schwartz, E.L. Langmack, J.L. Halliday, J.B. Trudeau, R.L. Gibbs, and et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics Am J Respir Crit Care Med 160 1999 1001 1008
11. G.W. Chalmers, K.J. MacLeod, L. Thomson, S.A. Little, C. McSharry, and N.C. Thomson Smoking and airway inflammation in patients with mild asthma Chest 120 2001 1917 1922
12. H. Andersen, P. Lampela, A. Nevanlinna, O. Saynajakangas, and T. Keistinen High hospital burden in overlap syndrome of asthma and COPD Clin Respir J 7 2013 342 346
13. R. de Marco, G. Pesce, A. Marcon, S. Accordini, L. Antonicelli, M. Bugiani, and et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population PLoS One 8 2013 e62985
14. D.M. Mannino, R.C. Gagnon, T.L. Petty, and E. Lydick Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994 Arch Intern Med 160 2000 1683 1689
15. J.B. Soriano, K.J. Davis, B. Coleman, G. Visick, D. Mannino, and N.B. Pride The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom Chest 124 2003 474 481
16. S.D. Aaron, K.L. Vandemheen, L.P. Boulet, R.A. McIvor, J.M. Fitzgerald, P. Hernandez, and et al. Overdiagnosis of asthma in obese and nonobese adults CMAJ 179 2008 1121 1131
17. V.P. Luks, K.L. Vandemheen, and S.D. Aaron Confirmation of asthma in an era of overdiagnosis Eur Respir J 36 2010 255 260
18. P. Montnémery, L. Hansson, J. Lanke, L.H. Lindholm, P. Nyberg, C.G. Löfdahl, and et al. Accuracy of a first diagnosis of asthma in primary health care Fam Pract 19 2002 365 368
19. L. Schirnhofer, B. Lamprecht, N. Firlei, B. Kaiser, A.S. Buist, R.J. Halbert, and et al. Using targeted spirometry to reduce non-diagnosed chronic obstructive pulmonary disease Respiration 81 2011 476 482
20. P. Kauppi, H. Kupiainen, A. Lindqvist, L. Tammilehto, M. Kilpelainen, V.L. Kinnula, and et al. Overlap syndrome of asthma and COPD predicts low quality of life J Asthma 48 2011 279 285
21. J.H. Lee, T. Haselkorn, L. Borish, L. Rasouliyan, B.E. Chipps, and S.E. Wenzel Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study Chest 132 2007 1882 1889
22. P.M. Calverley, P.S. Burge, S. Spencer, J.A. Anderson, and P.W. Jones Bronchodilator reversibility testing in chronic obstructive pulmonary disease Thorax 58 2003 659 664
23. N.A. Hanania, A. Sharafkhaneh, B. Celli, M. Decramer, T. Lystig, S. Kesten, and et al. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial Respir Res 12 2011 6
24. J. Travers, S. Marsh, B. Caldwell, M. Williams, S. Aldington, M. Weatherall, and et al. External validity of randomized controlled trials in COPD Respir Med 101 2007 1313 1320
25. J. Travers, S. Marsh, M. Williams, M. Weatherall, B. Caldwell, P. Shirtcliffe, and et al. External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax 62 2007 219 223
26. M.L. Levy, M. Fletcher, D.B. Price, T. Hausen, R.J. Halbert, and B.P. Yawn International Primary Care Respiratory Group (IPCRG) guidelines: diagnosis of respiratory diseases in primary care Prim Care Respir J 15 2006 20 34
27. S.C. Lazarus, H.A. Boushey, J.V. Fahy, V.M. Chinchilli, R.F. Lemanske Jr., C.A. Sorkness, and et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial JAMA 285 2001 2583 2593
28. S. Suissa, P. Ernst, S. Benayoun, M. Baltzan, and B. Cai Low-dose inhaled corticosteroids and the prevention of death from asthma N Engl J Med 343 2000 332 336
29. S. Suissa, P. Ernst, and A. Kezouh Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma Thorax 57 2002 880 884
30. E.D. Bateman, H.A. Boushey, J. Bousquet, W.W. Busse, T.J. Clark, R.A. Pauwels, and et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study Am J Respir Crit Care Med 170 2004 836 844
31. M. Masoli, S. Holt, M. Weatherall, and R. Beasley Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis Eur Respir J 23 2004 552 558
32. P.G. Gibson, and H. Powell Written action plans for asthma: an evidence-based review of the key components Thorax 59 2004 94 99
33. M. Zwerink, M. Brusse-Keizer, P.D. van der Valk, G.A. Zielhuis, E.M. Monninkhof, J. van der Palen, and et al. Self management for patients with chronic obstructive pulmonary disease Cochrane Database Syst Rev 3 2014 CD002990
34. N. Roche, H.K. Reddel, A. Agusti, E.D. Bateman, J.A. Krishnan, R.J. Martin, and et al. Integrating real-life studies in the global therapeutic research framework Lancet Respir Med 1 2013 e29 e30
35. L.K. Williams, E.L. Peterson, K. Wells, B.K. Ahmedani, R. Kumar, E.G. Burchard, and et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence J Allergy Clin Immunol 128 2011 1185 1191.e2
36. L.P. Boulet, J.M. FitzGerald, M.L. Levy, A.A. Cruz, S. Pedersen, T. Haahtela, and et al. A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care Eur Respir J 39 2012 1220 1229
37. M. Abramson, A.J. Crockett, E. Dabscheck, P.A. Frith, J. George, N. Glasgow, and et al. The COPD-X Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease V2.39 2014 Lung Foundation Australia Milton (Australia)
38. D.E. O'Donnell, S. Aaron, J. Bourbeau, P. Hernandez, D.D. Marciniuk, M. Balter, and et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update Can Respir J 14 suppl B 2007 5B 32B
39. H. Kankaanranta, T. Harju, M. Kilpelainen, W. Mazur, J.T. Lehto, M. Katajisto, and et al. Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the Finnish guidelines Basic Clin Pharmacol Toxicol 116 2015 291 307
40. M. Miravitlles, J.J. Soler-Cataluna, M. Calle, J. Molina, P. Almagro, J.A. Quintano, and et al. A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC) Prim Care Respir J 22 2013 117 121
41. M. Miravitlles, J.J. Soler-Cataluna, M. Calle, J. Molina, P. Almagro, J.A. Quintano, and et al. Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery Arch Bronconeumol 48 2012 247 257
42. J.J. Soler-Cataluna, B. Cosio, J.L. Izquierdo, J.L. Lopez-Campos, J.M. Marin, R. Aguero, and et al. Consensus document on the overlap phenotype COPD-asthma in COPD Arch Bronconeumol 48 2012 331 337
43. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update) 2010 National Institute for Health and Care Excellence London (United Kingdom) Available at: www.nice.org.uk/guidance/cg101 Accessed May 15, 2015
44. A. Qaseem, V. Snow, P. Shekelle, K. Sherif, T.J. Wilt, S. Weinberger, and et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians Ann Intern Med 147 2007 633 638
45. A. Qaseem, T.J. Wilt, S.E. Weinberger, N.A. Hanania, G. Criner, T. van der Molen, and et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society Ann Intern Med 155 2011 179 191
46. Australian Asthma Handbook V1.1 2015 National Asthma Council Australia Melbourne Available at: www.asthmahandbook.org.au Accessed May 15, 2015
47. M.D. Lougheed, C. Leniere, F.M. Ducharme, C. Licskai, S.D. Dell, B.H. Rowe, and et al. Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults: executive summary Can Respir J 19 2012 e81 e88
48. T. Haahtela, L. Lehtimäki, E. Ahonen, T. Harju, T. Jartti, H. Kankaanranta, and et al. Update on Current Care Guidelines: asthma Duodecim 129 2013 994 995
49. Executive Committee Gema GEMA 2009 (Spanish guideline on the management of asthma) J Investig Allergol Clin Immunol 20 suppl 1 2010 1 59
50. British guideline on the management of asthma. Available at: https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-guideline-2014/. Accessed May 15, 2015.
51. National Asthma Education and Prevention Program Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma - summary report 2007 J Allergy Clin Immunol 120 suppl 2007 S94 S138
52. L.M. Poulos, R.D. Ampon, G.B. Marks, and H.K. Reddel Inappropriate prescribing of inhaled corticosteroids: are they being prescribed for respiratory tract infections? A retrospective cohort study Prim Care Respir J 22 2013 201 208
53. P. White, H. Thornton, H. Pinnock, S. Georgopoulou, and H.P. Booth Overtreatment of COPD with inhaled corticosteroids - implications for safety and costs: cross-sectional observational study PLoS One 8 2013 e75221
54. M. Malerba, A. Radaeli, A. Olivini, G. Damiani, B. Ragnoli, P. Montuschi, and et al. Exhaled nitric oxide as a biomarker in COPD and related comorbidities Biomed Res Int 2014 2014 271918
55. S. Pascoe, N. Locantore, M.T. Dransfield, N.C. Barnes, and I.D. Pavord Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials Lancet Respir Med 3 2015 435 442
56. M. Bafadhel, S. McKenna, S. Terry, V. Mistry, M. Pancholi, P. Venge, and et al. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial Am J Respir Crit Care Med 186 2012 48 55
57. E. Israel, and A. Papi Severe asthma: pragmatic clinical lumping and time for investigational splitting Am J Respir Crit Care Med 189 2014 619 620